Gérard Collomb, Senator and Mayor of the city of Lyon in France, along with other representatives of Lyon and some of their business collaborators, paid a visit to the Institute’s La Jolla campus yesterday, where they met with Dr. Paul Laikind, Sanford-Burnham’s chief business officer.
In France, Mr. Collomb’s policies are driven by his focus on [...]

By MARLEY SEAMAN
AP Health Writer
NEW YORK (AP) – Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock.
Celgene Corp. said thetransaction could add $1 billion to its annual sales by 2015. The company is hoping it will [...]

It is our pleasure to inform you that Gerard Collomb, Senator of the Rhones-Alpes region and Mayor of the city of Lyon (France), will be in San Diego on July 22nd, 2010, along with his close collaborators and main representatives of the region of Lyon.
- M. [...]

This grant competition is targeted at early-career research leaders, of any age, with 2-12 years of experience after their PhD. The researchers can be of any nationality as long as they are working, or moving to work, in Europe.
The competition is open to proposals in any field of research (from Socials Sciences and Humanities to [...]

Source: http://www.science.doe.gov/News_Information/News_Room/2010/July%201_EarlyCareer.html
WASHINGTON, DC – The U.S. Department of Energy (DOE) announced today it is accepting proposals for the second year of the DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in their careers. Up to $15 million in funding will be awarded in 2011 to support [...]

source: http://online.wsj.com/article/SB10001424052748703571704575340880052218588.html
NEW YORK—Arena Pharmaceuticals Inc. signed a deal for Japanese drug maker Eisai Co. to sell experimental weight-loss drug lorcaserin in the U.S., if it is approved by the Food and Drug Administration.
The deal, the value of which largely rests upon the commercial success of lorcaserin, came earlier than expected as investors await the [...]

Title: “Cord Blood and Adult Stem Cells for biotechnology and regenerative medicine”Location: ARTERRA at the DEL MAR MARRIOTT 11966 El Camino Real Del Mar, CA CA 92130Link out: Click hereDescription: What?
We are glad to announce that we will be hosting a seminar by Professor Colin McGuckin entitled:
“Cord Blood and Adult Stem Cells for biotechnology [...]

Source: http://www.targegen.com/news063010.htm
San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN; NYSE: SNY). Under the agreement, the ultimate purchase price will depend on the achievement of certain future [...]